DAVITA INC

DaVita’s 2025 report shows 85% employee belonging and 30%+ Q2 earnings growth, earning top workplace titles while bolstering investor confidence in kidney dialysis.

DaVita’s Q1 2026 results beat earnings expectations, with $3.416B revenue and $198M net income, boosting its clinical‑care leadership and investor confidence.

DaVita’s Q4 2025 earnings beat expectations, with $2.34B revenue and $3.29 EPS, and a new Elara Caring investment signals growth in home‑based dialysis services.

DaVita Inc. stands out as a leader in kidney care services, driven by innovation, patient-centered care, and strong financial performance, positioning it for continued growth and success in the healthcare industry.